Wealth Architects, LLC Edwards Lifesciences Corp Transaction History

Wealth Architects, LLC

$906 Million
Q2 2025

A detailed history of Wealth Architects, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wealth Architects, LLC holds 2,829 shares of EW stock, worth $216,842. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,829

Previous 2,834 0.18%

Holding current value

$216,842

Previous $205,000 7.8%

% of portfolio

0.02%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 25, 2025	SELL	$67.07 - $78.22 $335 - $391	-5 Reduced 0.18%	2,829 $221,000
Q1 2025 May 14, 2025	BUY	$67.95 - $76.19 $177,893 - $199,465	2,618 Added 1212.04%	2,834 $205,000
Q1 2025 May 12, 2025	SELL	$67.95 - $76.19 $180,611 - $202,513	-2,658 Reduced 92.48%	216 $15,000
Q4 2024 Feb 10, 2025	BUY	$64.54 - $75.92 $185,487 - $218,194	2,874 New	2,874 $212,000
Q2 2024 Aug 08, 2024	BUY	$84.3 - $94.31 $758 - $848	9 Added 0.3%	2,966 $273,000
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $507 - $668	7 Added 0.24%	2,957 $282,000
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $182,044 - $229,392	2,950 New	2,950 $224,000
Q2 2023 Aug 02, 2023	SELL	$81.41 - $94.33 $5,780 - $6,697	-71 Reduced 2.26%	3,071 $289,000
Q1 2023 Apr 21, 2023	BUY	$74.26 - $84.51 $4,232 - $4,817	57 Added 1.85%	3,142 $259,000
Q4 2022 Feb 09, 2023	BUY	$68.3 - $87.44 $1,844 - $2,360	27 Added 0.88%	3,085 $230,000
Q3 2022 Oct 24, 2022	SELL	$82.37 - $107.29 $3,459 - $4,506	-42 Reduced 1.35%	3,058 $253,000
Q2 2022 Jul 29, 2022	SELL	$86.5 - $128.27 $7,612 - $11,287	-88 Reduced 2.76%	3,100 $295,000
Q1 2022 May 17, 2022	BUY	$101.96 - $128.34 $4,078 - $5,133	40 Added 1.27%	3,188 $375,000
Q4 2021 Jan 19, 2022	SELL	$106.37 - $130.68 $41,058 - $50,442	-386 Reduced 10.92%	3,148 $408,000
Q3 2021 Nov 09, 2021	BUY	$102.91 - $122.75 $205 - $245	2 Added 0.06%	3,534 $400,000
Q2 2021 Aug 09, 2021	BUY	$83.84 - $104.76 $19,786 - $24,723	236 Added 7.16%	3,532 $366,000
Q1 2021 Apr 29, 2021	BUY	$78.68 - $90.67 $7,395 - $8,522	94 Added 2.94%	3,296 $276,000
Q4 2020 Jan 28, 2021	BUY	$71.69 - $91.23 $716 - $912	10 Added 0.31%	3,202 $292,000
Q3 2020 Nov 09, 2020	SELL	$67.19 - $87.44 $67 - $87	-1 Reduced 0.03%	3,192 $255,000
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $122,214 - $163,441	2,124 Added 198.69%	3,193 $221,000
Q1 2020 Apr 23, 2020	SELL	$52.41 - $81.0 $419 - $648	-8 Reduced 0.74%	1,069 $202,000
Q4 2019 Jan 28, 2020	BUY	$71.7 - $82.09 $215 - $246	3 Added 0.28%	1,077 $251,000
Q3 2019 Oct 23, 2019	BUY	$61.55 - $75.43 $66,104 - $81,011	1,074 New	1,074 $236,000
Q2 2019 Jul 12, 2019	SELL	$55.74 - $64.41 $60,031 - $69,369	-1,077 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$47.89 - $64.05 $51,577 - $68,981	1,077 New	1,077 $206,000

Others Institutions Holding EW

# of Institutions

1,448

Shares Held

485M

Call Options Held

2.76M

Put Options Held

1.54M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $47.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Architects, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Architects, LLC with notifications on news.

Account

Wealth Architects, LLC Edwards Lifesciences Corp Transaction History